Skip to main content
Erschienen in: Esophagus 1/2017

02.08.2016 | Review Article

Diagnosis and treatment of eosinophilic esophagitis in Japan

verfasst von: Yoshikazu Kinoshita, Norihisa Ishimura, Tsuyoshi Mishiro, Shunji Ishihara, Kyoichi Adachi

Erschienen in: Esophagus | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Patients in Japan affected by eosinophilic esophagitis (EoE), considered to be a dietary allergen related chronic esophageal disease, are slowly increasing. For diagnosis, careful assessments of atopic diathesis and symptoms, an endoscopic examination focusing on EoE characteristic findings, and histopathological examination of appropriate biopsy samples are important. When clinicopathological examination results suggest EoE, proton pump inhibitor (PPI) administration should be attempted to determine the response (PPI-responsive esophageal eosinophilia, PPI-REE). For PPI-refractory cases, oral topical glucocorticoid administration is the first therapeutic option, followed by systemic glucocorticoids as necessary. Evidence-based guidelines are currently under development in Japan for standardizing diagnosis and treatment.
Literatur
1.
Zurück zum Zitat Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–92.CrossRefPubMed Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–92.CrossRefPubMed
2.
Zurück zum Zitat Lucendo AJ, Arias Á, Molina-Infante J, et al. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice. Dig Liver Dis. 2013;45:562–8.CrossRefPubMed Lucendo AJ, Arias Á, Molina-Infante J, et al. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice. Dig Liver Dis. 2013;45:562–8.CrossRefPubMed
3.
Zurück zum Zitat Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128:1349–50.CrossRefPubMed Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128:1349–50.CrossRefPubMed
4.
Zurück zum Zitat Giriens B, Yan P, Safroneeva E, et al. Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population-based study. Allergy. 2015;70:1633–9.CrossRefPubMed Giriens B, Yan P, Safroneeva E, et al. Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population-based study. Allergy. 2015;70:1633–9.CrossRefPubMed
5.
Zurück zum Zitat Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055–61.CrossRefPubMedPubMedCentral Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009;7:1055–61.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol. 2013;48:333–9.CrossRefPubMed Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol. 2013;48:333–9.CrossRefPubMed
7.
Zurück zum Zitat Kinoshita Y, Ishimura N, Oshima N, et al. Systematic review: eosinophilic esophagitis in Asian countries. World J Gastroenterol. 2015;21:8433–40.CrossRefPubMedPubMedCentral Kinoshita Y, Ishimura N, Oshima N, et al. Systematic review: eosinophilic esophagitis in Asian countries. World J Gastroenterol. 2015;21:8433–40.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Cianferoni A, Spergel JM. Eosinophilic esophagitis and gastroenteritis. Curr Allergy Asthma Rep. 2015;15:58.CrossRefPubMed Cianferoni A, Spergel JM. Eosinophilic esophagitis and gastroenteritis. Curr Allergy Asthma Rep. 2015;15:58.CrossRefPubMed
9.
Zurück zum Zitat Caldwell JM, Collins MH, Stucke EM, et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol. 2014;134:1114–24.CrossRefPubMedPubMedCentral Caldwell JM, Collins MH, Stucke EM, et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol. 2014;134:1114–24.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(3–20):e6. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(3–20):e6.
11.
Zurück zum Zitat Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230–6.e1-2. Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230–6.e1-2.
12.
Zurück zum Zitat Runge TM, Eluri S, Cotton CC, et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype. Am J Gastroenterol. 2016;111:206–13.CrossRefPubMed Runge TM, Eluri S, Cotton CC, et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the fibrostenotic phenotype. Am J Gastroenterol. 2016;111:206–13.CrossRefPubMed
13.
Zurück zum Zitat Fujishiro H, Amano Y, Kushiyama Y, et al. Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients. J Gastroenterol. 2011;46:1142–4.CrossRefPubMed Fujishiro H, Amano Y, Kushiyama Y, et al. Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients. J Gastroenterol. 2011;46:1142–4.CrossRefPubMed
14.
Zurück zum Zitat Fujiwara Y, Sugawa T, Tanaka F, et al. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration. Intern Med. 2012;51:3235–9.CrossRefPubMed Fujiwara Y, Sugawa T, Tanaka F, et al. A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration. Intern Med. 2012;51:3235–9.CrossRefPubMed
15.
Zurück zum Zitat Tomomatsu Y, Yoshino J, Inui K, et al. Clinical features of eosinophilic esophagitis: ten Japanese cases. Dig Endosc. 2013;25:117–24.CrossRefPubMed Tomomatsu Y, Yoshino J, Inui K, et al. Clinical features of eosinophilic esophagitis: ten Japanese cases. Dig Endosc. 2013;25:117–24.CrossRefPubMed
16.
Zurück zum Zitat Fujiwara Y, Tanigawa T, Yamagami H, et al. Eosinophilic esophagitis-like endoscopic findings in patients with erosive esophagitis. Esophagus. 2013;10:199–204.CrossRef Fujiwara Y, Tanigawa T, Yamagami H, et al. Eosinophilic esophagitis-like endoscopic findings in patients with erosive esophagitis. Esophagus. 2013;10:199–204.CrossRef
17.
Zurück zum Zitat Shimura S, Ishimura N, Tanimura T, et al. Reliability of symptoms and endoscopic findings for diagnosis of esophageal eosinophilia in a Japanese population. Digestion. 2014;90:49–57.CrossRefPubMed Shimura S, Ishimura N, Tanimura T, et al. Reliability of symptoms and endoscopic findings for diagnosis of esophageal eosinophilia in a Japanese population. Digestion. 2014;90:49–57.CrossRefPubMed
18.
Zurück zum Zitat Hori K, Watari J, Fukui H, et al. Do endoscopic features suggesting eosinophilic esophagitis represent histological eosinophilia? Dig Endosc. 2014;26:156–63.CrossRefPubMed Hori K, Watari J, Fukui H, et al. Do endoscopic features suggesting eosinophilic esophagitis represent histological eosinophilia? Dig Endosc. 2014;26:156–63.CrossRefPubMed
19.
Zurück zum Zitat Adachi K, Mishiro T, Tanaka S, et al. Suitable biopsy site for detection of esophageal eosinophilia in eosinophilic esophagitis suspected cases. Dig Endosc. 2016;28:139–44.CrossRefPubMed Adachi K, Mishiro T, Tanaka S, et al. Suitable biopsy site for detection of esophageal eosinophilia in eosinophilic esophagitis suspected cases. Dig Endosc. 2016;28:139–44.CrossRefPubMed
20.
Zurück zum Zitat Fujiwara H, Morita A, Kobayashi H, et al. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2002;89:429–32.CrossRefPubMed Fujiwara H, Morita A, Kobayashi H, et al. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2002;89:429–32.CrossRefPubMed
21.
Zurück zum Zitat Furuta K, Adachi K, Kowari K, et al. A Japanese case of eosinophilic esophagitis. J Gastroenterol. 2006;41:706–10.CrossRefPubMed Furuta K, Adachi K, Kowari K, et al. A Japanese case of eosinophilic esophagitis. J Gastroenterol. 2006;41:706–10.CrossRefPubMed
22.
Zurück zum Zitat Kamimura K, Oosaki A, Sugahara S, et al. Eosinophilic esophagitis: a case report. Effective treatment with systemic corticosteroids for the relapse of the disease. Clin. J Gastroenterol. 2008;1:46–51. Kamimura K, Oosaki A, Sugahara S, et al. Eosinophilic esophagitis: a case report. Effective treatment with systemic corticosteroids for the relapse of the disease. Clin. J Gastroenterol. 2008;1:46–51.
23.
Zurück zum Zitat Sano H, Iwakiri K, Kawami N, et al. Eosinophilic esophagitis: a case report with a review of the literature. Clin J Gastroenterol. 2010;3:279–84.CrossRefPubMed Sano H, Iwakiri K, Kawami N, et al. Eosinophilic esophagitis: a case report with a review of the literature. Clin J Gastroenterol. 2010;3:279–84.CrossRefPubMed
24.
Zurück zum Zitat Tamagawa Y, Miyake T, Mishiro T, et al. A case of eosinophilic esophagitis with atypical clinical course. Clin J Gastroenterol. 2011;4:202–6.CrossRefPubMed Tamagawa Y, Miyake T, Mishiro T, et al. A case of eosinophilic esophagitis with atypical clinical course. Clin J Gastroenterol. 2011;4:202–6.CrossRefPubMed
25.
Zurück zum Zitat Abe Y, Iijima K, Ohara S, et al. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol. 2011;46:25–30.CrossRefPubMed Abe Y, Iijima K, Ohara S, et al. A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol. 2011;46:25–30.CrossRefPubMed
26.
Zurück zum Zitat Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56:615–20.CrossRefPubMed Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56:615–20.CrossRefPubMed
27.
Zurück zum Zitat Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134:1316–21.CrossRefPubMed Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134:1316–21.CrossRefPubMed
28.
Zurück zum Zitat Shoda T, Morita H, Nomura I, et al. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries. Allergol Int. 2015;64:260–5.CrossRefPubMed Shoda T, Morita H, Nomura I, et al. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries. Allergol Int. 2015;64:260–5.CrossRefPubMed
29.
Zurück zum Zitat Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536–47.CrossRefPubMedPubMedCentral Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536–47.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kinoshita Y, Ishimura N, Oshima N, et al. Recent Progress in the Research of Eosinophilic Esophagitis and Gastroenteritis. Digestion. 2016;93:7–12.CrossRefPubMed Kinoshita Y, Ishimura N, Oshima N, et al. Recent Progress in the Research of Eosinophilic Esophagitis and Gastroenteritis. Digestion. 2016;93:7–12.CrossRefPubMed
31.
Zurück zum Zitat Ishimura N, Shimura S, Jiao D, et al. Clinical features of eosinophilic esophagitis: differences between Asian and Western populations. J Gastroenterol Hepatol. 2015;30(Suppl 1):71–7.CrossRefPubMed Ishimura N, Shimura S, Jiao D, et al. Clinical features of eosinophilic esophagitis: differences between Asian and Western populations. J Gastroenterol Hepatol. 2015;30(Suppl 1):71–7.CrossRefPubMed
32.
Zurück zum Zitat Sperry SL, Crockett SD, Miller CB, et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74:985–91.CrossRefPubMedPubMedCentral Sperry SL, Crockett SD, Miller CB, et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74:985–91.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Furuta K, Adachi K, Aimi M, et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53:60–2.CrossRefPubMedPubMedCentral Furuta K, Adachi K, Aimi M, et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53:60–2.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Dellon ES, Peery AF, Shaheen NJ, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141:1586–92.CrossRefPubMedPubMedCentral Dellon ES, Peery AF, Shaheen NJ, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141:1586–92.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(1084–92):e1. Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(1084–92):e1.
36.
Zurück zum Zitat Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–91.CrossRefPubMedPubMedCentral Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–91.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46:895–900.CrossRefPubMedPubMedCentral Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46:895–900.CrossRefPubMedPubMedCentral
39.
40.
Zurück zum Zitat Müller S, Pühl S, Vieth M, et al. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy. 2007;39:339–44.CrossRefPubMed Müller S, Pühl S, Vieth M, et al. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy. 2007;39:339–44.CrossRefPubMed
41.
Zurück zum Zitat Genevay M, Rubbia-Brandt L, Rougemont AL. Do eosinophil numbers differentiate eosinophilic esophagitis from gastroesophageal reflux disease? Arch Pathol Lab Med. 2010;134:815–25.PubMed Genevay M, Rubbia-Brandt L, Rougemont AL. Do eosinophil numbers differentiate eosinophilic esophagitis from gastroesophageal reflux disease? Arch Pathol Lab Med. 2010;134:815–25.PubMed
42.
Zurück zum Zitat Ali MA, Lam-Himlin D, Voltaggio L. Eosinophilic esophagitis: a clinical, endoscopic, and histopathologic review. Gastrointest Endosc. 2012;76:1224–37.CrossRefPubMed Ali MA, Lam-Himlin D, Voltaggio L. Eosinophilic esophagitis: a clinical, endoscopic, and histopathologic review. Gastrointest Endosc. 2012;76:1224–37.CrossRefPubMed
43.
Zurück zum Zitat Ishimura N, Furuta K, Sato S, et al. Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders. J Gastroenterol Hepatol. 2013;28:1306–13.CrossRefPubMed Ishimura N, Furuta K, Sato S, et al. Limited role of allergy testing in patients with eosinophilic gastrointestinal disorders. J Gastroenterol Hepatol. 2013;28:1306–13.CrossRefPubMed
44.
Zurück zum Zitat Kinoshita Y, Furuta K, Ishimura N, et al. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion. 2012;86:238–43.CrossRefPubMed Kinoshita Y, Furuta K, Ishimura N, et al. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion. 2012;86:238–43.CrossRefPubMed
45.
Zurück zum Zitat Dellon ES, Rusin S, Gebhart JH, et al. Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: a prospective study. Am J Gastroenterol. 2015;110:821–7.CrossRefPubMedPubMedCentral Dellon ES, Rusin S, Gebhart JH, et al. Utility of a noninvasive serum biomarker panel for diagnosis and monitoring of eosinophilic esophagitis: a prospective study. Am J Gastroenterol. 2015;110:821–7.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Jiao D, Ishimura N, Maruyama R, et al. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. J Gastroenterol. 2016 Apr 23. [Epub ahead of print]. Jiao D, Ishimura N, Maruyama R, et al. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients. J Gastroenterol. 2016 Apr 23. [Epub ahead of print].
47.
Zurück zum Zitat Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–95.CrossRefPubMed Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–95.CrossRefPubMed
48.
Zurück zum Zitat Abe Y, Iijima K, Ohara S, et al. Localized esophageal eosinophilia: is it an early manifestation of eosinophilic esophagitis or a subtype of gastroesophageal reflux disease? Dig Endosc. 2014;26:337–43.CrossRefPubMed Abe Y, Iijima K, Ohara S, et al. Localized esophageal eosinophilia: is it an early manifestation of eosinophilic esophagitis or a subtype of gastroesophageal reflux disease? Dig Endosc. 2014;26:337–43.CrossRefPubMed
49.
Zurück zum Zitat Aceves SS, Chen D, Newbury RO, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126:1198–204.CrossRefPubMed Aceves SS, Chen D, Newbury RO, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126:1198–204.CrossRefPubMed
50.
Zurück zum Zitat Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28:383–90.CrossRefPubMed Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28:383–90.CrossRefPubMed
51.
Zurück zum Zitat Nielsen JA, Lager DJ, Lewin M, et al. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis. Am J Gastroenterol. 2014;109:515–20.CrossRefPubMed Nielsen JA, Lager DJ, Lewin M, et al. The optimal number of biopsy fragments to establish a morphologic diagnosis of eosinophilic esophagitis. Am J Gastroenterol. 2014;109:515–20.CrossRefPubMed
52.
Zurück zum Zitat Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr. 2009;154:96–100.CrossRefPubMed Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr. 2009;154:96–100.CrossRefPubMed
53.
Zurück zum Zitat Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108:1854–60.CrossRefPubMedPubMedCentral Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108:1854–60.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Moawad FJ, Schoepfer AM, Safroneeva E, et al. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther. 2014;39:603–8.CrossRefPubMed Moawad FJ, Schoepfer AM, Safroneeva E, et al. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharmacol Ther. 2014;39:603–8.CrossRefPubMed
55.
Zurück zum Zitat Wen T, Dellon ES, Moawad FJ, et al. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol. 2015;135:187–97.CrossRefPubMed Wen T, Dellon ES, Moawad FJ, et al. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol. 2015;135:187–97.CrossRefPubMed
56.
Zurück zum Zitat Ishimura N, Ishihara S, Kinoshita Y. Sustained acid suppression by potassium-competitive acid blocker (P-CAB) may be an attractive treatment candidate for patients with eosinophilic esophagitis. Am J Gastroenterol (in press). Ishimura N, Ishihara S, Kinoshita Y. Sustained acid suppression by potassium-competitive acid blocker (P-CAB) may be an attractive treatment candidate for patients with eosinophilic esophagitis. Am J Gastroenterol (in press).
57.
Zurück zum Zitat Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184:4033–41.CrossRefPubMed Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184:4033–41.CrossRefPubMed
58.
Zurück zum Zitat Kottyan LC, Collier AR, Cao KH, et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood. 2009;114:2774–82.CrossRefPubMedPubMedCentral Kottyan LC, Collier AR, Cao KH, et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood. 2009;114:2774–82.CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824–32.CrossRefPubMed Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824–32.CrossRefPubMed
60.
Zurück zum Zitat Henderson CJ, Abonia JP, King EC, et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129:1570–8.CrossRefPubMedPubMedCentral Henderson CJ, Abonia JP, King EC, et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129:1570–8.CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Gonsalves N, Yang GY, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(1451–9):e1. Gonsalves N, Yang GY, Doerfler B, et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(1451–9):e1.
62.
Zurück zum Zitat Peterson KA, Byrne KR, Vinson LA, et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108:759–66.CrossRefPubMed Peterson KA, Byrne KR, Vinson LA, et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108:759–66.CrossRefPubMed
63.
Zurück zum Zitat Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1272–9.CrossRefPubMedPubMedCentral Wolf WA, Jerath MR, Sperry SL, et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1272–9.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(1526–37):e1. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(1526–37):e1.
65.
Zurück zum Zitat Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10:742–9.CrossRefPubMed Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10:742–9.CrossRefPubMed
66.
Zurück zum Zitat Dellon ES, Sheikh A, Speck O, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143:321–4.CrossRefPubMedPubMedCentral Dellon ES, Sheikh A, Speck O, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143:321–4.CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–9.CrossRefPubMed Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–9.CrossRefPubMed
68.
Zurück zum Zitat Straumann A, Hoesli S, Bussmann Ch, et al. Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy. 2013;68:375–85.CrossRefPubMed Straumann A, Hoesli S, Bussmann Ch, et al. Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy. 2013;68:375–85.CrossRefPubMed
69.
Zurück zum Zitat Straumann A, Bussmann C, Conus S, et al. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425–7.CrossRefPubMed Straumann A, Bussmann C, Conus S, et al. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122:425–7.CrossRefPubMed
70.
Zurück zum Zitat Foster B, Foroughi S, Yin Y, et al. Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy. 2011;9:7.CrossRefPubMedPubMedCentral Foster B, Foroughi S, Yin Y, et al. Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy. 2011;9:7.CrossRefPubMedPubMedCentral
71.
Zurück zum Zitat Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456–63.CrossRefPubMed Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129:456–63.CrossRefPubMed
72.
Zurück zum Zitat Assa’ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141:1593–604.CrossRefPubMed Assa’ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141:1593–604.CrossRefPubMed
73.
Zurück zum Zitat Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59:21–30.CrossRefPubMed Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59:21–30.CrossRefPubMed
74.
Zurück zum Zitat Rothenberg ME, Wen T, Greenberg A, et al. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135:500–7.CrossRefPubMed Rothenberg ME, Wen T, Greenberg A, et al. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135:500–7.CrossRefPubMed
Metadaten
Titel
Diagnosis and treatment of eosinophilic esophagitis in Japan
verfasst von
Yoshikazu Kinoshita
Norihisa Ishimura
Tsuyoshi Mishiro
Shunji Ishihara
Kyoichi Adachi
Publikationsdatum
02.08.2016
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 1/2017
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-016-0550-8

Weitere Artikel der Ausgabe 1/2017

Esophagus 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.